Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with HLH. Dr Verkamp is a hematology/oncology fellow in the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital. Hear from Dr Verkamp about her research, findings, and important considerations for assessing patient response to first-line etoposide-based HLH therapy.
Follow Us
- YouTube @Sobi-Pharma
- Linkedin @Sobi
Presented by Sobi Inc.
©2023 Sobi, Inc. All rights reserved. NP-32204 12/23